Well, let's see if the news of September 28, 2022, will be updated.
https://www.resverlogix.com/investors/news.html?article=721
"The Company is finalizing the Phase 3 study protocol of apabetalone in PCC and plans to launch the trial in the first half of 2023, subject to all necessary regulatory and other applicable approvals and securing the necessary resources."
Koo